In 2000, the Southwest Cancer Clinical and Nevada Radiation Oncology Centers merged to expand the treatment services they provided to cancer patients. In 2002 these two groups took on the name Comprehensive Cancer Centers of Nevada. The union of the hospitals, which had been operating for more than 35 years, has since expanded to include 12 treatment centers across the state. With branches in the different neighborhoods of Los Vegas, Henderson and Boulder City, Nevada-based cancer patients have many choices for local cancer care with the CCCN network
In 1995, before the merger, the groups’ doctors joined US Oncology, one of the largest health care networks in the nation, well-known as an oncology-specific organization and now CCCN’s parent company. US Oncology’s 9,000 cancer professionals and 1,000 doctors lead their fields in treatment and research.
Comprehensive Cancer Centers of Nevada has been affiliated with Jonsson Comprehensive Cancer Center (JCCC) at UCLA for more than 15 years, offering Southern Nevada patients opportunities to participate in cutting-edge clinical trials. In fact, the CCCN partnership with Jonsson was created to augment JCCC’s community-based research and clinical trials, as Jonsson realized that CCCN physician researchers were among the best in their field.
Mesothelioma patients who choose to visit the Comprehensive Cancer Centers of Nevada may be directed to the Central Valley treatment center in Las Vegas. Renowned mesothelioma doctor Nicholas Vogelzang, M.D., has practiced at this campus since 2009 after directing the National Cancer Institute for five years. Vogelzang is one of the center’s attending oncologists, but the staff also includes a radiation oncologist and a licensed pathologist.
3730 S. Eastern Avenue, Las Vegas, NV, 89169
With an on-site laboratory and pharmacy, the centers allow patients to obtain multiple types of medical attention in one convenient setting. Financial counseling and educational services such as chemotherapy classes are also offered at their facilities.
Progressive medicine has been the focus of the CCCN since its founding. To enhance their research efforts, the centers partner with the Jonsson Comprehensive Cancer Center at UCLA. In 2003, they joined UCLA’s Translational Oncology Research International Network to specially focus on the evaluation of new therapeutic drugs and treatment methods. Each year CCCN conducts more than 150 Phase I, Phase II and Phase III clinical trials. As of August 2011, more than 180 active clinical trials were in place, including a “Randomized Phase II Study Of Maintenance Pemetrexed Versus Observation For Patients With Malignant Pleural Mesothelioma Without Progression After First Line Chemotherapy.”
Disclaimer: Nevada Comprehensive Cancer Center has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.
View our resources for patients and familiesGet Help Today